# Cerebroprotective Effect of Melatonin in Stroke

Study · id `cardio:ct-nct05857046` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05857046](<https://clinicaltrials.gov/study/NCT05857046>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05857046

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05857046. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2025-03-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05857046, source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)
- Started: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05857046, source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)
- Primary completion: 2025-03-15 (anticipated) (ClinicalTrials.gov record NCT05857046, source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)
- Completion: 2025-07-14 (anticipated) (ClinicalTrials.gov record NCT05857046, source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)
- Countries: Mexico (ClinicalTrials.gov record NCT05857046, source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05857046-2024-03-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cerebroprotective Effect of Melatonin in Stroke
- Condition: Stroke, Acute Ischemic
- Condition: Strokes Thrombotic
- Intervention (Drug): Melatonin 10 MG
- Intervention (Other): Placebo
- Lead sponsor: Coordinación de Investigación en Salud, Mexico
- Lead sponsor class: OTHER\_GOV
- Collaborator: Instituto Mexicano del Seguro Social
- Collaborator class: OTHER\_GOV
- Collaborator: Universidad Michoacana de San Nicolás de Hidalgo
- Collaborator class: UNKNOWN
- Collaborator: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (`cardio:org-instituto-de-seguridad-y-servicios-sociales-de-los-4e32a0`)

## Provenance

Content hash: 8221f95ea682b880fbb328b64b028c049f3d190c5a0a52e7a07107717f918766
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
